Altius Healthcare
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(514) 868-8437Website
www.altiushealthcare.caRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Altius Healthcare
Altius Healthcare Group L.P. is a Canadian pharmaceutical company dedicated to helping Canadians achieve their wellness goals through safe, effective, and affordable healthcare solutions. They specialize in providing authorized generic versions of proven brand name drugs, leveraging strategic partnerships to maintain high quality and production standards. With over 40 years of experience in the pharmaceutical industry, Altius focuses on enhancing healthcare affordability and accessibility. Their mission is to offer reliable, cost-effective alternatives to brand name medications, ensuring patients have access to essential healthcare products.Explore more
Altius Healthcare Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Altius Healthcare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Altius Healthcare is spiking on competitors!
Product Launch: Get notified when Altius Healthcare launches new products
Congratulate Masked Content for being promoted to Masked Content at Altius Healthcare
Earning: See what the market has to say on Altius Healthcare recently announced quarterly report
Click to see if Altius Healthcare had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Altius Healthcare has new funding data
Website visits: Recent activity has been detected on your website
Altius Healthcare, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Altius Healthcare has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Altius Healthcare
Find more new buyers
Compare Similar Companies to Altius Healthcare
Compare insights from companies similar to Altius Healthcare, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Altius Healthcare is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Altius Healthcare is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Altius Healthcare.
Altius Healthcare Tech Stack
A closer look at the technologies used by Altius Healthcare
Most Recent Scoops
New Hire
Executive Move
Lateral Move
Executive Move
New Hire
Executive Move
New Hire
Executive Move
Altius Healthcare News & Media
Devonian Reports Its Annual 2024 Financial Results
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces, as of November 28, 2024, financial results for its fiscal year ended July 31, 2024. Management Comments “This has been a breakout year for Devonian,” said Luc Grégoire, President and Chief Executive Officer of Devonian. “While contiDevonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor Relations Firm
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its third quarter ended on April 30, 2024. Management Comments “This has been a breakout quarter for Devonian,” said Luc Gregoire, President and CEO of Devonian. “While continuing our scientific activities for the continued development of Thykamine for atopic dermatitis (eczema), our quarter was highlighted by a 1,162% revenue growth at Altius,Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its second quarter ended on January 31, 2024. Management Comments "This has been a truly transformative quarter for Devonian,” said Luc Gregoire, President and CEO of Devonian. “While shoring up our organization structure and focusing our activities for the continued development of ThykamineTM for atopic dermatitis, we have made significant posiDevonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
QUÉBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased to announce that its wholly-owned subsidiary, Altius Healthcare Inc. (“Altius”), has launched the first authorized generic of dexlansoprazole (Dexilant®) in Canada to treat symptoms of gastroesophageal reflux disease (
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Altius Healthcare
Sign Up For FreeTo access detailed company insights
Altius Healthcare Group L.P. is a Canadian pharmaceutical company dedicated to helping Canadians achieve their wellness goals through safe, effective, and affordable healthcare solutions. They specialize in providing authorized generic versions of proven brand name drugs, leveraging strategic partnerships to maintain high quality and production sta... Read More
